全球COVID-19治疗药物市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测

预计到2030年，全球COVID-19治疗药物市场需求将从2022年的339.2亿美元增长到749.6亿美元，2023-2030年的复合年增长率为10.42%。

COVID-19疗法是指用于治疗由SARS-CoV-2病毒引起的呼吸道疾病COVID-19的药物和疗法。COVID-19疗法包括抗病毒药物、免疫调节药物和单克隆抗体等。COVID-19疗法的目标是减轻症状、预防并发症和改善COVID-19患者的总体预后。

市场动态：

COVID-19大流行导致对COVID-19治疗药物的高需求，原因是病例数量不断增加，需要有效的治疗方案。世界各国政府正在提供资金和支持，以加速COVID-19疗法的开发和供应。这导致了研发投资的增加，以及监管部门对加快批准潜在疗法的支持。新变种的出现导致对能有效治疗这些新病毒株的COVID-19疗法的需求增加。随着科学界对COVID-19的进一步了解，新的治疗靶点正在被确定，从而开发出可能更有效治疗该疾病的新型疗法。包括制药公司和研究机构在内的医疗机构之间的合作正在推动COVID-19疗法的开发和供应。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于在全球范围内清晰地了解行业结构并评估竞争吸引力。此外，这些工具还对COVID-19疗法全球市场的各个细分市场进行了全面评估。COVID-19治疗剂行业的增长和趋势为本研究提供了整体方法。

市场细分：

COVID-19治疗剂市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按药物类别

• 皮质类固醇
• 抗病毒药物
• 单克隆抗体
• 激酶抑制剂
• 其他（抗炎药物、康复血浆、其他）

按给药途径

• 口服
• 肠外

按销售渠道

• 医院药房
• 零售药店
• 网上药店

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美以及中东和非洲地区COVID-19治疗药物市场的当前和未来需求。此外，报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

• 全球COVID-19治疗剂各地区市场份额（代表图）
• 全球COVID-19治疗药物市场份额

研究报告还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。COVID-19治疗剂市场的主要参与者包括F.Hoffmann-La Roche Ltd、Gilead Sciences Inc、Eli Lilly and Company、Pfizer Inc、Merck & Co.Inc., GSK plc, Celltrion Healthcare Co.Ltd、Sorrento Therapeutics、AstraZeneca plc。本部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

如果您有任何定制要求，请联系我们。我们的研究团队可以根据您的需求提供定制报告。

目 录

第一章：前言

• 报告描述
  • 报告目标
  • 目标受众
  • 独特销售主张（USP）和产品
• 研究范围
• 研究方法
  • 市场调研流程
  • 市场调研方法

第二章：执行摘要

• 市场亮点
• 全球市场概况

第3章：Covid-19疗法 - 行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制因素
• 市场机会
• 行业趋势
• 波特五力分析
• 市场吸引力分析
  • 按药物类别分類的市场吸引力分析
  • 按给药途径的市场吸引力分析
  • 按销售渠道的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原材料制造商列表
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直接营销
  • 间接营销
  • 营销渠道发展趋势

第五章：covid-19爆发的影响分析

第六章：全球covid-19治疗药物市场分析：按药物类别划分

• 按药物类别概述
• 历史和预测数据
• 按药物类别分析
• 皮质类固醇
• 抗病毒药物
• 单克隆抗体
• 激酶抑制剂
• 其他（抗炎药物、康复血浆、其他）

第七章 ：全球Covid-19治疗药物市场分析：按给药途径分类

• 给药途径概述
• 历史和预测数据
• 按给药途径分析
• 口服
• 肠外

第八章：全球covid-19治疗药物市场销售分析：按分销渠道分析

• 分销渠道概述
• 历史和预测数据
• 按销售渠道分析
• 医院药房
• 零售药店
• 网上药店

第9章：全球Covid-19治疗剂市场销售分析：按地区划分

• 地区展望 销售分析
• 销售分析
• 北美销售分析
  • 概述，历史和预测销售分析
  • 北美地区销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区各细分市场销售分析
  • 亚太地区各国销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东及非洲地区销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第10章 : Covid-19治疗剂公司的竞争格局

• Covid-19治疗剂市场竞争格局
• 伙伴关系/合作/协议
• 合并与收购
• 新产品上市
• 其他发展

第十一章 ：公司概况

• 前10强企业份额分析
• 市场集中率
• F.Hoffmann-La Roche Ltd
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Gilead Sciences Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Eli Lilly and Company
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Pfizer Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Merck & Co. Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• GSK plc
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Celltrion Healthcare Co. Ltd
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Sorrento Therapeutics
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• AstraZeneca plc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

The global demand for COVID-19 Therapeutics Market is presumed to reach the market size of nearly USD 74.96 BN by 2030 from USD 33.92 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.

COVID-19 therapeutics refer to the drugs and therapies used for the treatment of COVID-19, the respiratory illness caused by the SARS-CoV-2 virus. COVID-19 therapeutics include antiviral drugs, immunomodulatory drugs, and monoclonal antibodies, among others. The goal of COVID-19 therapeutics is to reduce the severity of symptoms, prevent complications, and improve the overall outcomes of patients with COVID-19.

Market Dynamics:

The COVID-19 pandemic has resulted in high demand for COVID-19 therapeutics due to the increasing number of cases and the need for effective treatment options. Governments worldwide are providing funding and support to accelerate the development and availability of COVID-19 therapeutics. This has led to increased investment in research and development, as well as regulatory support for the expedited approval of potential therapies. The emergence of new variants has led to an increased need for COVID-19 therapeutics that can effectively treat these new strains of the virus. New therapeutic targets are being identified as the scientific community learns more about COVID-19, leading to the development of novel therapies that may be more effective in treating the disease. Collaboration among healthcare organizations, including pharmaceutical companies and research institutions, is driving the development and availability of COVID-19 therapeutics.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of COVID-19 therapeutics. The growth and trends of COVID-19 therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the COVID-19 therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

• Corticosteroids
• Anti-Viral
• Monoclonal Antibodies
• Kinase Inhibitors
• Others (Anti-Inflammatory Drugs, Convalescent Plasma, Others)

By Route Of Administration

• Oral
• Parenteral

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the COVID-19 Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

• Global COVID-19 Therapeutics Market Share by Region (Representative Graph)
• Global COVID-19 Therapeutics Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the COVID-19 therapeutics market include F.Hoffmann-La Roche Ltd, Gilead Sciences Inc., Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., GSK plc, Celltrion Healthcare Co. Ltd, Sorrento Therapeutics, AstraZeneca plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . COVID-19 THERAPEUTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Drug Class
  • 3.7.2 Market Attractiveness Analysis By Route Of Administration
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL COVID-19 THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

• 6.1 Overview by Drug Class
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Drug Class
• 6.4 Corticosteroids Historic and Forecast Sales by Regions
• 6.5 Anti-viral Historic and Forecast Sales by Regions
• 6.6 Monoclonal Antibodies Historic and Forecast Sales by Regions
• 6.7 Kinase Inhibitors Historic and Forecast Sales by Regions
• 6.8 Others (Anti-inflammatory Drugs, Convalescent Plasma, Others) Historic and Forecast Sales by Regions

7 . GLOBAL COVID-19 THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1 Overview by Route Of Administration
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Route Of Administration
• 7.4 Oral Historic and Forecast Sales by Regions
• 7.5 Parenteral Historic and Forecast Sales by Regions

8 . GLOBAL COVID-19 THERAPEUTICS MARKET SALES ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1 Overview by Distribution Channel
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Distribution Channel
• 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
• 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
• 8.6 Online Pharmacies Historic and Forecast Sales by Regions

9 . GLOBAL COVID-19 THERAPEUTICS MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE COVID-19 THERAPEUTICS COMPANIES

• 10.1. Covid-19 Therapeutics Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF COVID-19 THERAPEUTICS INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. F.Hoffmann-La Roche Ltd
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Gilead Sciences Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Eli Lilly and Company
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Pfizer Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Merck & Co. Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. GSK plc
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Celltrion Healthcare Co. Ltd
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Sorrento Therapeutics
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. AstraZeneca plc.
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Drug Class (USD MN)
• Corticosteroids Market Sales by Geography (USD MN)
• Anti-viral Market Sales by Geography (USD MN)
• Monoclonal Antibodies Market Sales by Geography (USD MN)
• Kinase Inhibitors Market Sales by Geography (USD MN)
• Others (Anti-inflammatory Drugs, Convalescent Plasma, Others) Market Sales by Geography (USD MN)
• Analysis Market by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Analysis by Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Retail Pharmacies Market Sales by Geography (USD MN)
• Online Pharmacies Market Sales by Geography (USD MN)
• Global Covid-19 Therapeutics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Covid-19 Therapeutics Report
• Market Research Process
• Market Research Methodology
• Global Covid-19 Therapeutics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Drug Class
• Market Attractiveness Analysis by Route Of Administration
• Market Attractiveness Analysis by Distribution Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Drug Class (USD MN)
• Corticosteroids Market Sales by Geography (USD MN)
• Anti-viral Market Sales by Geography (USD MN)
• Monoclonal Antibodies Market Sales by Geography (USD MN)
• Kinase Inhibitors Market Sales by Geography (USD MN)
• Others (Anti-inflammatory Drugs, Convalescent Plasma, Others) Market Sales by Geography (USD MN)
• Global Market Analysis by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Global Market Analysis by Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Retail Pharmacies Market Sales by Geography (USD MN)
• Online Pharmacies Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above lis